Article: Ovarian and cervical cancer

Death rates from cervical cancer have already fallen this century and for patients with invasive cervical cancer five year survival rates are greater than for most solid tumours. Better screening for premalignant changes may further reduce the incidence of invasive cancer; indeed, it has been claimed that the reduction in mortality could be as high as 90%, though estimates of screening efficacy have varied greatly. For those with advanced invasive carcinoma neoadjuvant chemotherapy may reduce the risk of relapse and improve survival.

Citing Articles

The effect of dose-painted intensity-modulated radiotherapy combined with chemotherapy for stage IIIB cervical cancer.

Liu Y, Zang C, Qian L, Wu A, Ke X Am J Transl Res. 2021; 13(4):2813-2821.

PMID: 34017444 PMC: 8129359.

Quality of life in patients with ovarian cancer: current state of research.

Montazeri A, McEwen J, Gillis C Support Care Cancer. 1996; 4(3):169-79.

PMID: 8739648 DOI: 10.1007/BF01682336.

Ovarian cancer and ABO blood groups.

Henderson J, Seagroatt V, Goldacre M J Epidemiol Community Health. 1993; 47(4):287-9.

PMID: 8228763 PMC: 1059794. DOI: 10.1136/jech.47.4.287.

References

1.

Heintz A, Van Oosterom A, Trimbos J, SCHABERG A, van der Velde E, Nooy M . The treatment of advanced ovarian carcinoma (I): clinical variables associated with prognosis. Gynecol Oncol. 1988; 30(3):347-58. DOI: 10.1016/0090-8258(88)90249-1. View

2.

Buxton E, Meanwell C, Hilton C, Mould J, Spooner D, Chetiyawardana A . Combination bleomycin, ifosfamide, and cisplatin chemotherapy in cervical cancer. J Natl Cancer Inst. 1989; 81(5):359-61. DOI: 10.1093/jnci/81.5.359. View

3.

RICHARDSON G, Scully R, Nikrui N, NELSON Jr J . Common epithelial cancer of the ovary (2). N Engl J Med. 1985; 312(7):415-24. DOI: 10.1056/NEJM198502143120706. View

4.

Lynch H, Bewtra C, Lynch J . Familial ovarian carcinoma. Clinical nuances. Am J Med. 1986; 81(6):1073-6. DOI: 10.1016/0002-9343(86)90411-0. View

5.

Perez C, CAMEL H, Kao M, Askin F . Randomized study of preoperative radiation and surgery or irradiation alone in the treatment of stage IB and IIA carcinoma of the uterine cervix: preliminary analysis of failures and complications. Cancer. 1980; 45(11):2759-68. DOI: 10.1002/1097-0142(19800601)45:11<2759::aid-cncr2820451110>3.0.co;2-0. View

6.

AVERETTE H, LaPlatney D, Little W . Current role of radical hysterectomy as primary therapy for invasive carcinoma of the cervix. Am J Obstet Gynecol. 1969; 105(1):79-89. DOI: 10.1016/0002-9378(69)90160-4. View

7.

CULLHED S . Carcinoma cervicis uteri stages I and IIa. Treatment - histopathology - prognosis. Acta Obstet Gynecol Scand Suppl. 1978; 75:1-149. View

8.

Morley G, Seski J . Radical pelvic surgery versus radiation therapy for stage I carcinoma of the cervix (exclusive of microinvasion). Am J Obstet Gynecol. 1976; 126(7):785-98. DOI: 10.1016/0002-9378(76)90668-2. View

9.

Smith J, RUTLEDGE F, DELCLOS L . Postoperative treatment of early cancer of the ovary: a random trial between postoperative irradiation and chemotherapy. Natl Cancer Inst Monogr. 1975; 42:149-53. View

10.

Jampolis S, Andras E, FLETCHER G . Analysis of sites and causes of failures of irradiation in invasive squamous cell carcinoma of the intact uterine cervix. Radiology. 1975; 115(3):681-5. DOI: 10.1148/15.3.681. View

11.

Dembo A, Bush R, Beale F, Bean H, PRINGLE J, STURGEON J . The Princess Margaret Hospital study of ovarian cancer: stages I, II, and asymptomatic III presentations. Cancer Treat Rep. 1979; 63(2):249-54. View

Ovarian and Cervical Cancer